Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Lisa M Forman

TitleProfessor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-MED

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Bowlus CL, Eksteen B, Cheung AC, Thorburn D, Moylan CA, Pockros PJ, Forman LM, Dorenbaum A, Hirschfield GM, Kennedy C, Jaecklin T, McKibben A, Chien E, Baek M, Vig P, Levy C. Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study. Hepatol Commun. 2023 06 01; 7(6). PMID: 37184523.
      View in: PubMed
    2. Hirschfield GM, Shiffman ML, Gulamhusein A, Kowdley KV, Vierling JM, Levy C, Kremer AE, Zigmond E, Andreone P, Gordon SC, Bowlus CL, Lawitz EJ, Aspinall RJ, Pratt DS, Raikhelson K, Gonzalez-Huezo MS, Heneghan MA, Jeong SH, Ladr?n de Guevara AL, Mayo MJ, Dalekos GN, Drenth JPH, Janczewska E, Leggett BA, Nevens F, Vargas V, Zuckerman E, Corpechot C, Fassio E, Hinrichsen H, Invernizzi P, Trivedi PJ, Forman L, Jones DEJ, Ryder SD, Swain MG, Steinberg A, Boudes PF, Choi YJ, McWherter CA. Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study. Hepatology. 2023 08 01; 78(2):397-415. PMID: 37386786.
      View in: PubMed
    3. Bowlus CL, Arriv? L, Bergquist A, Deneau M, Forman L, Ilyas SI, Lunsford KE, Martinez M, Sapisochin G, Shroff R, Tabibian JH, Assis DN. Reply: Insurance should cover vancomycin for primary sclerosing cholangitis. Hepatology. 2023 06 01; 77(6):E176-E177. PMID: 36695291.
      View in: PubMed
    4. Forman LM, Sapisochin G, Assis DN, Arriv? L, Bergquist A, Bowlus CL, Deneau M, Ilyas SI, Lunsford KE, Martinez M, Shroff R, Tabibian JH. Reply: Living donor liver transplantation for people with PSC. Hepatology. 2023 05 01; 77(5):E97-E98. PMID: 36732294.
      View in: PubMed
    5. Bowlus CL, Arriv? L, Bergquist A, Deneau M, Forman L, Ilyas SI, Lunsford KE, Martinez M, Sapisochin G, Shroff R, Tabibian JH, Assis DN. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology. 2023 02 01; 77(2):659-702. PMID: 36083140.
      View in: PubMed
    6. Kowdley KV, Forman L, Eksteen B, Gunn N, Sundaram V, Landis C, Harrison SA, Levy C, Liberman A, Di Bisceglie AM, Hirschfield GM. A Randomized, Dose-Finding, Proof-of-Concept Study of Berberine Ursodeoxycholate in Patients With Primary Sclerosing Cholangitis. Am J Gastroenterol. 2022 11 01; 117(11):1805-1815. PMID: 36327436.
      View in: PubMed
    7. Swei EC, Brar AK, Rice JD, Kim II, Knez VM, Doe CF, Forman LM. Statin-Induced Rhabdomyolysis Associated With Transjugular Intrahepatic Portosystemic Shunt Placement. ACG Case Rep J. 2022 May; 9(5):e00774. PMID: 35919670.
      View in: PubMed
    8. Francis P, Forman LM. Statins Show Promise Against Progression of Liver Disease. Clin Liver Dis (Hoboken). 2021 Dec; 18(6):280-287. PMID: 34976372.
      View in: PubMed
    9. Yan K, Forman L. Cannabinoid Use Among Liver Transplant Recipients. Liver Transpl. 2021 11; 27(11):1623-1632. PMID: 34018308.
      View in: PubMed
    10. Francis P, Forman L. HATs Off to Clot Blockers: A Potential New Role for Statins After Transplantation. Liver Transpl. 2021 10; 27(10):1375-1377. PMID: 34118130.
      View in: PubMed
    11. Cristin DJ, Forman LM, Jackson WE. Beyond Survival: Targeting Health-Related Quality of Life Outcomes After Liver Transplantation. Clin Liver Dis (Hoboken). 2021 May; 17(5):359-364. PMID: 34136142.
      View in: PubMed
    12. Leehey MA, Liu Y, Hart F, Epstein C, Cook M, Sillau S, Klawitter J, Newman H, Sempio C, Forman L, Seeberger L, Klepitskaya O, Baud Z, Bainbridge J. Safety and Tolerability of Cannabidiol in Parkinson Disease: An Open Label, Dose-Escalation Study. Cannabis Cannabinoid Res. 2020; 5(4):326-336. PMID: 33381646.
      View in: PubMed
    13. Francis P, Forman L. Use of Statins in Patients With and Without Liver Disease. Clin Liver Dis (Hoboken). 2020 Jan; 15(1):40-45. PMID: 32104577.
      View in: PubMed
    14. Bowlus CL, Pockros PJ, Kremer AE, Par?s A, Forman LM, Drenth JPH, Ryder SD, Terracciano L, Jin Y, Liberman A, Pencek R, Iloeje U, MacConell L, Bedossa P. Long-Term Obeticholic Acid Therapy Improves Histological Endpoints in Patients With Primary Biliary Cholangitis. Clin Gastroenterol Hepatol. 2020 05; 18(5):1170-1178.e6. PMID: 31606455.
      View in: PubMed
    15. Kalra A, Burton JR, Forman LM. Pro: Steroids Can Be Withdrawn After Transplant in Recipients With Autoimmune Hepatitis. Liver Transpl. 2018 08; 24(8):1109-1112. PMID: 29923302.
      View in: PubMed
    16. Goldberg DS, Levy C, Yimam K, Gordon SC, Forman L, Verna E, Yu L, Rahimi R, Schwarz K, Eksteen B, Pratt D, Boyer JL, Assis D, Bowlus C. Primary Sclerosing Cholangitis Is Not Rare Among Blacks in a Multicenter North American Consortium. Clin Gastroenterol Hepatol. 2018 04; 16(4):591-593. PMID: 29102704.
      View in: PubMed
    17. Kohli R, Fenton HH, Forman L. Unusual Cause of Elevated Liver Enzymes in a Female Patient. Gastroenterology. 2018 May; 154(6):1588-1589. PMID: 28807843.
      View in: PubMed
    18. Wilkey BJ, Hanson R, Reece TB, Forman L, Burton JR, Messenger JC, Kim MS, Cleveland JC, Fiegel MJ, Nydam TL, Mandell MS. Transfemoral Transcatheter Aortic Valve Replacement for Mixed Aortic Valve Disease in Child's Class C Liver Disease Prior to Orthotopic Liver Transplantation: A Case Report. Semin Cardiothorac Vasc Anesth. 2016 Jun; 20(2):158-62. PMID: 26620139.
      View in: PubMed
    19. Campos-Varela I, Lai JC, Verna EC, O'Leary JG, Todd Stravitz R, Forman LM, Trotter JF, Brown RS, Terrault NA. Hepatitis C genotype influences post-liver transplant outcomes. Transplantation. 2015 Apr; 99(4):835-40. PMID: 25211520.
      View in: PubMed
    20. Goldberg DS, Camp A, Martinez-Camacho A, Forman L, Fortune B, Reddy KR. Risk of waitlist mortality in patients with primary sclerosing cholangitis and bacterial cholangitis. Liver Transpl. 2013 Mar; 19(3):250-8. PMID: 23213009.
      View in: PubMed
    21. Biggins SW, Trotter J, Gralla J, Burton JR, Bambha KM, Dodge J, Brocato M, Cheng L, McQueen M, Forman L, Chang M, Kam I, Everson G, Spritz RA, Klintmalm G, Rosen HR. Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation. J Hepatol. 2013 May; 58(5):969-76. PMID: 23333445.
      View in: PubMed
    22. Lai JC, O'Leary JG, Trotter JF, Verna EC, Brown RS, Stravitz RT, Duman JD, Forman LM, Terrault NA. Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: a multicenter cohort study. Liver Transpl. 2012 May; 18(5):532-8. PMID: 22271671.
      View in: PubMed
    23. Lai JC, Verna EC, Brown RS, O'Leary JG, Trotter JF, Forman LM, Duman JD, Foster RG, Stravitz RT, Terrault NA. Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men. Hepatology. 2011 Aug; 54(2):418-24. PMID: 21538434.
      View in: PubMed
    24. Fortune BE, Francis S, Forman LM. Hepatitis C Virus Therapy-related Skin Manifestations. Gastroenterol Hepatol (N Y). 2010 May; 6(5):326-8. PMID: 20567589.
      View in: PubMed
    25. Weber NK, Forman LM, Trotter JF. HBIg discontinuation with maintenance oral anti-viral therapy and HBV vaccination in liver transplant recipients. Dig Dis Sci. 2010 Feb; 55(2):505-9. PMID: 19802696.
      View in: PubMed
    26. Heller JC, Prochazka AV, Everson GT, Forman LM. Long-term management after liver transplantation: primary care physician versus hepatologist. Liver Transpl. 2009 Oct; 15(10):1330-5. PMID: 19790168.
      View in: PubMed
    27. Campsen J, Zimmerman MA, Mandell MS, Wachs M, Bak T, Forman L, Steinberg T, Kam I. Hepaticoduodenostomy is an alternative to Roux-en-Y hepaticojejunostomy for biliary reconstruction in live donor liver transplantation. Transplantation. 2009 Jun 27; 87(12):1842-5. PMID: 19543062.
      View in: PubMed
    28. Forman LM. Metabolic syndrome in liver transplantation: the elephant in the room. Liver Transpl. 2008 Sep; 14(9):1245-8. PMID: 18756450.
      View in: PubMed
    29. Fallon MB, Krowka MJ, Brown RS, Trotter JF, Zacks S, Roberts KE, Shah VH, Kaplowitz N, Forman L, Wille K, Kawut SM. Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates. Gastroenterology. 2008 Oct; 135(4):1168-75. PMID: 18644373.
      View in: PubMed
    30. Trotter JF, Campsen J, Bak T, Wachs M, Forman L, Everson G, Kam I. Outcomes of donor evaluations for adult-to-adult right hepatic lobe living donor liver transplantation. Am J Transplant. 2006 Aug; 6(8):1882-9. PMID: 16889543.
      View in: PubMed
    31. Everson GT, Trotter J, Forman L, Kugelmas M, Halprin A, Fey B, Ray C. Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy. Hepatology. 2005 Aug; 42(2):255-62. PMID: 16025497.
      View in: PubMed
    32. Slater K, Ludkowski M, Mehling J, Forman L, Pieramici E, Wachs M, Kam I, Bak T. Hepatic artery pseudoaneurysm - duodenal fistula after living donor liver transplant. Clin Transplant. 2004 Dec; 18(6):734-6. PMID: 15516253.
      View in: PubMed
    33. Hayashi PH, Mao J, Slater K, Liao R, Durham JD, Carroll J, Everson GT, Kam I, Forman LM. Atrial septal perforation from TIPS stent migration. J Vasc Interv Radiol. 2004 Jun; 15(6):629-32. PMID: 15178725.
      View in: PubMed
    34. Hayashi PH, Ludkowski M, Forman LM, Osgood M, Johnson S, Kugelmas M, Trotter JF, Bak T, Wachs M, Kam I, Durham J, Everson GT. Hepatic artery chemoembolization for hepatocellular carcinoma in patients listed for liver transplantation. Am J Transplant. 2004 May; 4(5):782-7. PMID: 15084175.
      View in: PubMed
    35. Forman LM, Trotter JF, Emond J. Living donor liver transplantation and hepatitis C. Liver Transpl. 2004 Mar; 10(3):347-8. PMID: 15004759.
      View in: PubMed
    36. Forman LM, Lucey MR. Setting limits on selection of adults for liver transplantation. Transplantation. 2004 Jan 15; 77(1):19-21. PMID: 14750510.
      View in: PubMed
    37. Medeiros BC, Seligman PA, Everson GT, Forman LM. Possible autoimmune thrombocytopenia associated with pegylated interferon-alpha2a plus ribavarin treatment for hepatitis C. J Clin Gastroenterol. 2004 Jan; 38(1):84-6. PMID: 14679335.
      View in: PubMed
    38. Abt PL, Desai NM, Crawford MD, Forman LM, Markmann JW, Olthoff KM, Markmann JF. Survival following liver transplantation from non-heart-beating donors. Ann Surg. 2004 Jan; 239(1):87-92. PMID: 14685105.
      View in: PubMed
    39. Hayashi PH, Trotter JF, Forman L, Kugelmas M, Steinberg T, Russ P, Wachs M, Bak T, Kam I, Everson GT. Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD. Liver Transpl. 2004 Jan; 10(1):42-8. PMID: 14755776.
      View in: PubMed
    40. Kugelmas M, Osgood MJ, Trotter JF, Bak T, Wachs M, Forman L, Kam I, Everson GT. Hepatitis C virus therapy, hepatocyte drug metabolism, and risk for acute cellular rejection. Liver Transpl. 2003 Nov; 9(11):1159-65. PMID: 14586876.
      View in: PubMed
    41. Everson GT, Trotter JF, Kugelmas M, Forman L. Immunosuppression in liver transplantation. Minerva Chir. 2003 Oct; 58(5):725-40. PMID: 14603151.
      View in: PubMed
    42. Forman LM. To transplant or not to transplant recurrent hepatitis C and liver failure. Clin Liver Dis. 2003 Aug; 7(3):615-29. PMID: 14509530.
      View in: PubMed
    43. Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients. Liver Transpl. 2003 Jul; 9(7):737-40. PMID: 12827562.
      View in: PubMed
    44. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology. 2002 Apr; 122(4):889-96. PMID: 11910340.
      View in: PubMed
    45. Forman LM, Lucey MR. Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo End-stage Liver Disease. Hepatology. 2001 Feb; 33(2):473-5. PMID: 11172352.
      View in: PubMed
    46. Saur CD, Granger BB, Muhlbaier LH, Forman LM, McKenzie RJ, Taylor MC, Smith PK. Depressive symptoms and outcome of coronary artery bypass grafting. Am J Crit Care. 2001 Jan; 10(1):4-10. PMID: 11153183.
      View in: PubMed
    47. Forman LM, Simmons DA, Diamond RH. Hepatic failure in a patient taking rosiglitazone. Ann Intern Med. 2000 Jan 18; 132(2):118-21. PMID: 10644272.
      View in: PubMed
    48. Mack AH, Forman L, Brown R, Frances A. A brief history of psychiatric classification. From the ancients to DSM-IV. Psychiatr Clin North Am. 1994 Sep; 17(3):515-23. PMID: 7824378.
      View in: PubMed
    Forman's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (205) concept(s)
    _
    Co-Authors Expand Description
    See all (16) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)